Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial.
Baron D, Pace Loscos T, Schiappa R, Barbet N, Dost E, Ben Dhia S, Soltani S, Mineur L, Martel I, Horn S, Picardi C, Stewart A, Cotte E, Coquard R, Baudin G, Evesque L, Dhadda A, Sun Myint A, Gérard JP, Doyen J; ICONE group. Baron D, et al. Among authors: pace loscos t. Ann Oncol. 2024 Nov 10:S0923-7534(24)04904-4. doi: 10.1016/j.annonc.2024.10.827. Online ahead of print. Ann Oncol. 2024. PMID: 39532203
'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
Mitrea D, Barbet N, Pacé-Loscos T, Scouarnec C, Ben-Dhia S, Baron D, Mineur L, Évesque L, Durand-Labrunie J, Gérard JP, Baudin G, Doyen J. Mitrea D, et al. Among authors: pace loscos t. Cancer Radiother. 2024 Aug;28(4):323-332. doi: 10.1016/j.canrad.2024.02.003. Epub 2024 Jul 14. Cancer Radiother. 2024. PMID: 39003168
Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation.
Janho Dit Hreich S, Humbert O, Pacé-Loscos T, Schiappa R, Juhel T, Ilié M, Ferrari V, Benzaquen J, Hofman P, Vouret-Craviari V. Janho Dit Hreich S, et al. Among authors: pace loscos t. Cancers (Basel). 2024 Jun 14;16(12):2226. doi: 10.3390/cancers16122226. Cancers (Basel). 2024. PMID: 38927931 Free PMC article.
Response to "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients - A closer inspection will improve your vision".
Baron D, Pasquier D, Pace-Loscos T, Vandendorpe B, Schiappa R, Ortholan C, Hannoun-Levi JM. Baron D, et al. Among authors: pace loscos t. Clin Transl Radiat Oncol. 2024 Feb 21;46:100755. doi: 10.1016/j.ctro.2024.100755. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38440793 Free PMC article. No abstract available.
Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis.
Baron D, Pasquier D, Pace-Loscos T, Vandendorpe B, Schiappa R, Ortholan C, Hannoun-Levi JM. Baron D, et al. Among authors: pace loscos t. Clin Transl Radiat Oncol. 2023 Dec 8;45:100710. doi: 10.1016/j.ctro.2023.100710. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38179575 Free PMC article.
The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Sun Myint A, Rao C, Barbet N, Thamphya B, Pace-Loscos T, Schiappa R, Magné N, Martel-Lafay I, Mineur L, Deberne M, Zilli T, Dhadda A, Gerard JP. Sun Myint A, et al. Among authors: pace loscos t. Colorectal Dis. 2023 Nov;25(11):2160-2169. doi: 10.1111/codi.16773. Epub 2023 Oct 13. Colorectal Dis. 2023. PMID: 37837240 Clinical Trial.
16 results